RWR
Beyond's analysis on RWR
Recent news mentioning RWR
- — Centrus Announces Pricing of $500 Million Underwritten Public Offering of Class A Common Stock and Warrants
- — Centrus Announces Proposed Public Underwritten Offering of Class A Common Stock and Warrants
- — GEARWRENCH Continues to Expand Offering with Shop Cleaning Products
- — Robinhood Lands Crypto.com Deal, Underwriting Job For Oura. Goldman Hikes Target.
- — AXIS Celebrates 25th Anniversary, Launches Global Brand Campaign Spotlighting Its Focus on Specialty Underwriting Leadership
- — Robinhood Wins a New Role in the Oura IPO: Underwriter
- — Loews (L) Grows Profit And Book Value, But Underwriting Slips
- — Medigap Underwriters Don’t Take Your Word on the Health Questions. They Pull Your Pharmacy Records, and the Prescription Answers for You.
- — Corgi Insurance Launches 'Corgi Re' to Modernize Reinsurance With Technology-Driven Underwriting
- — Usurance Secures Utah License, Enters U.S. Insurance Underwriting Market
- — Leaving Medicare Advantage Takes One Phone Call. Getting the Medigap Policy That Makes Leaving Affordable Can Require Medical Underwriting.
- — Could Arrowhead Pharmaceuticals (ARWR)’s Plozasiran Become the Catalyst for a Major Stock Re-rating?